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Available online 24 August 2016Transgene-mediated programming is a preeminent strategy to direct cellular identity. To facilitate cell fate
switching, lineage regulating genes must be efﬁciently and uniformly induced. However, gene expression is
often heterogeneous in transgenic systems. Consistent with this notion, a non-uniform reporter gene expression
was detected in our doxycycline (DOX)-regulated, murine embryonic stem (ES) cell clones. Interestingly, a sig-
niﬁcant fraction of cells within each clone failed to produce any reporter signals upon DOX treatment. We
found that the majority of these non-responsive cells neither carry reporter transgene nor geneticin/G418 resis-
tance. This observation suggested that our ES cell clones contained non-recombined cells that survived the G418
selection which was carried out during the establishment of these clones. We successfully eliminated most of
these corrupted cells with repeated chemical (G418) selection, however, even after prolonged G418 treatments,
a few cells remained non-responsive due to epigenetic silencing. We found that cell sorting has been the most
efﬁcient approach to select those cells which can uniformly and stably induce the integrated transgene in this
ES cell based platform. Together, our data revealed that post-cloning chemical re-selection or cell sorting strongly









Mouse embryonic stem cells
Transgenic cells1. Introduction
Transgene-mediated cell conversion is a widely used strategy to ma-
nipulate cellular identity (Graf and Enver, 2009). Ectopically expressed
transcription factors are routinely used to reprogram somatic cells into in-
duced pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006;
Yamanaka, 2012), moreover overexpression of lineage determining tran-
scription factors can stimulate direct lineage conversions (Chambers and
Studer, 2011; Lee and Young, 2013; Morris and Daley, 2013). In addition,
embryonic stem (ES) cell differentiation can be directed by forced expres-
sion of lineage restricted transcription factors (Kyba et al., 2002;Wang et
al., 2005). To achieve a controllable, uniform expression, transgenes are
often integrated into a speciﬁc chromosomal locus and their expression
is driven by a DOX-responsive promoter. Numerous technologies are
available for targeting a gene of interest into a predetermined genomicEGFP, enhanced
ssette exchange.
, Hungary.
en access article underregion. For example, homologous recombination can be employed using
genome editing technologies (Merkert and Martin, 2016), or recombina-
tionmediated cassette exchange can be carried out on a pre-modiﬁed ge-
nomic locus (Ting et al., 2005; Turan et al., 2013). In this reportwe applied
a recently developed inducible cassette exchange recombination method
(Iacovino et al., 2011; Iacovino et al., 2014) for site speciﬁc gene targeting.
We used a mouse ES cell line (ZX1) (Dandapat et al., 2014), that en-
codes a DOX-inducible ﬂoxed Cre, which substitutes itself with an in-
coming gene of interest upon recombination (Iacovino et al., 2011;
Iacovino et al., 2014). In parallel, a special promoter plus ATG sequences
are inserted upstream of the neomycin resistance gene which restores
resistance to neomycin/geneticin in the recombined ES cells (Fig. 1).
Various versions of this inducible system have been applied to enhance
hematopoietic or skeletal muscle development by forced expression of
lineage speciﬁc transcription factors (Darabi et al., 2008; Kyba et al.,
2002).
In spite of these advanced gene targeting technologies, there is a
general problem with the transgenic systems, namely heterogeneity
and instability of transgene expression. Consistent with this notion, in
this report, we observed a heterogeneous transgene induction in our
DOX-regulated ES cell clones. We found that the majority of the non-the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Inducible cassette exchange recombination. The targeting plasmid (p2lox) can be
recombined with the inducible cassette exchange (ICE) target locus, which is located
upstream of the Hprt gene on the X chromosome. At the ICE target locus a second
generation tetracycline response element (sgTRE) drives expression of a Cre transgene
before recombination. Arrows indicate recombination between homologous loxP sites
that are represented by triangles. After Cre-mediated recombination the incoming gene
is placed downstream of the sgTRE, and the PGK-promoter plus ATG sequences are
introduced upstream of the neo (neomycin/geneticin resistant) gene. In addition, ZX1
ES cells constitutively express the reverse tetracycline transactivator (rtTA), which is
encoded in the ROSA26 locus (on Chromosome 6).
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non-recombined cells survived/reformed during the establishment of
these cell lines. Importantly, these non-responsive cells can be efﬁcient-
ly eliminated by chemical (G418) re-selection or cell sorting.
2. Materials and methods
2.1. Chemicals
Na-butyrate, 5-aza-2′-deoxycytidine (azadC) and doxycycline
(DOX) were obtained from Sigma-Aldrich. Geneticin (G418) was pur-
chased from Life Technologies.
2.2. Targeting vector construction
The coding sequences of the EGFP and mCherry genes were ampli-
ﬁedwith Gateway compatible attB-attached primers. Primer sequences
are shown in Table S1. The PCR products were subcloned into the
pDONR221 entry plasmid with Gateway technology (Invitrogen-Life
Technologies). The entry clones carrying the transgenes were
recombined with a Gateway compatible plasmid vector (p2lox-GW).
2.3. ES cell culture
The parental ZX1 mouse ES cell line (Dandapat et al., 2014) and the
newly generated mouse ES cell clones were cultured on primarymouse
embryonic ﬁbroblast (MEF) feeder layers during the establishment and
expansion of the genetically modiﬁed ES cell lines. In contrast, ES cells
were maintained without MEF feeder on gelatin pre-coated dish for
testing the transgene inducibility. ES cells were maintained in knockout
DMEM (Life Technologies) as described (Szatmari et al., 2010).
2.4. Generation of DOX-inducible ES cell clones
DOX-inducible ES cell clones were produced as described (Iacovino
et al., 2014)withminormodiﬁcations. In brief, ZX1 ES cells were treated
with DOX (1 μg/ml) one day before transfection in order to induce theCre enzyme. The transgene bearing p2lox targeting vectors were intro-
duced into the ZX1 cells by electroporation using the Neon Transfection
System (Life-Technologies). For electroporation single pulse was ap-
plied with 1400 V at 10 ms. After electroporation ES cells were seeded
on G418 resistant, mitomycin-C treated, mouse embryonic ﬁbroblast
(PMEF-N; Merck-Millipore) layers in 6-well plates and selected with
300 μg/ml G418 containing knockout-DMEM medium (Life-Technolo-
gies) for 7–8 days. After selection ES cell colonies were picked and
replated on MEF layers for expansion.
2.5. Genomic PCR
Genomic DNAwas puriﬁed with a High Pure PCR Template Prepara-
tion Kit (Roche). Quantitative PCR was carried out by real-time PCR
(Light Cycler 480; Roche) as described (Szatmari et al., 2010). In brief,
40 cycles at 95 °C for 12 s and 60 °C for 30 s using ﬂuorescence reporter
probes. Assay ID or primer/probe sequences are listed in Table S1. The
mCherry speciﬁc PCR reactions were done in triplicate, relative copy
number was determined by the comparative threshold cycle method
and normalized to the Maf gene.
Cre genewas detectedwith end-point PCRusing a Cre-speciﬁc prim-
er set (primer sequences are in Table S1). 100 ng genomic DNAwas am-
pliﬁed under the following conditions: 3 min at 94 °C; 30 cycles of
denaturation at 95 °C for 30 s, annealing at 56 °C for 30 s, extension at
72 °C for 30; and a ﬁnal extension at 72 °C for 5 min.
2.6. Flow cytometric analysis and cell sorting
Flow cytometric analysis and cell sortingwas performedwith a FACS
Aria III (BD Biosciences) sorter. 488 and 561 nm lasers were used to ex-
cite EGFP and mCherry, respectively and ﬂuorescence signals were col-
lectedwith a 530/30 band pass (BP) ﬁlter for EGFP and 610/20 BP ﬁlters
for mCherry. For cell separation approximately150,000 mCherry posi-
tive and negative ES cells were sorted. Sorted cells were expanded in
knockout-DMEMmedium using feeder-free ES cell culture conditions.
3. Results
3.1. Bimodal distribution of reporter signal in DOX-induced ES cells
Transgene-mediated programming is a popular strategy to manipu-
late cellular identity during ES cell differentiation. We intended to opti-
mize this transgene mediated cell conversion approach, therefore we
created inducible ES cell clones carrying reporter transgenes. DOX-con-
trolled cell clones were engineered with a previously developed induc-
ible cassette exchange recombination method (Iacovino et al., 2011;
Iacovino et al., 2014) as described in Materials and methods. In this
transgenic system, the properly recombined, individual male ES cells
carry one copy of integrated DNA segment in chromosome X (Fig. 1).
Therefore, this platform allows us to monitor the expression of a single
copy, inducible transgene.
First, we examined the mCherry reporter gene expression of the in-
dividual ES cell clones with ﬂuorescence microscopy. Strikingly, among
themCherry bright cellswe observed numerous cells lacking any appar-
ent reporter signals in all of the investigated ES cell clones (Fig. 2A). In
the following experiments we quantitated the distribution of the re-
porter positive and negative cells in the whole population by ﬂow cy-
tometry. Consistent with the microscopic data, an overt intraclonal
transgene expression heterogeneity was obtained in the reporter carry-
ing ES cells. All of the tested ES clones exhibited a bimodal distribution
of mCherry reporter signal (Fig. 2B and C). Bimodal distribution means
that a fraction of cells failed to produce any reporter signals, in contrast
the rest of the cells weremCherry positive. Similarly, heterogeneous re-
porter expression patternswere detected in EGFP carrying ES cell clones
(Fig. S1) suggesting that the bimodal distribution proﬁle is a general
characteristic of this inducible system. In summary, our analyses
AB
C
Fig. 2. Bimodal expression of mCherry protein in DOX treated ES cell clones. ES cell clones (C1–C5) were cultured in the presence (2 μg/ml) or absence of DOX for 2 days. (A) Microscopic
detection of ﬂuorescence reporter signals from mCherry carrying ES cell clones. Composite pictures (phase contrast plus ﬂuorescence) were generated with a Floid cell imaging station
(20× plan ﬂuorite objective, scale bar is indicated). (B) Representative ﬂow cytometric proﬁles of the mCherry speciﬁc clones. The mCherry ﬂuorescence is plotted on the x axis;
forward scatter (FSC) is plotted on the y axis. The percentage of cells falling within the positive gate is shown. (C) Average percentage of the mCherry positivity of the DOX-treated
(2 μg/ml) reporter cell clones. The average and the SD values were calculated from 3 independent experiments.
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porter expression and a subset of ES cells was unable to express the
transgene.
3.2. Improved transgene induction upon repeated chemical (G418)
selection
Our ﬂow cytometric analyses indicated that at least 10% of the cells
failed to express any reporter signals in the investigated ES cell clones.
It is possible that the non-responsive cells had insufﬁcient sensitivity
to DOX or a limited drug-uptake capacity. To test this possibility, two
transgenic ES cell clones were treated with graded amounts of DOX
(2–8 μg/ml) for two days (Fig. 3A). Despite of the elevated concentra-
tions of DOX, we failed to obtain a consistently improved reporter
gene expression, suggesting that antibiotic concentration is not the lim-
iting factor in this inducible system.
To further investigate thepotential reasons of the expression hetero-
geneity, we took the advantage that during the targeting plasmid inte-
gration a functional neomycin resistance gene is formed that renders
the recombined ES cells resistant to neomycin/G418 (Fig. 1). We
employed a prolonged (7–8 days) G418 (300 μg/ml) selection during
the establishment of these ES cell clones to eliminate the non-
recombined ES cells. Despite of this initial chemical selection, however,
it is possible that some non-recombined ES cells survived or some of
them lost their G418 resistance during the ES cell expansion which
were carried out without chemical (G418) selection. To verify thispossibility, themCherry speciﬁc ES cell cloneswere cultured in the pres-
ence or absence of G418 (300 μg/ml) for 8 days. Interestingly, elevated
percent of mCherry expressing cells was detected in all transgenic
clones although we never reached 100% positivity after re-selection
(Fig. 3B). This ﬁnding suggested that a considerable fraction of the
non-responsive cells were G418-sensitive; elimination of these cells
by a second round of G418 selection substantially improved the trans-
gene inducibility of these ES cells.
3.3. Genetic heterogeneity is responsible for the impaired transgene
induction
Our data revealed that a fraction of cells was refractory to DOX treat-
ment in all investigated mCherry bearing ES cell clones and most of
these unresponsive cells were G418 sensitive. We reasoned that either
genetic alterations and/or epigenetic silencing were responsible for
the compromised transgene expression. Therefore, we tested the integ-
rity of the mCherry transgene from the DOX responsive and non-re-
sponsive ES cells. To achieve this, two mCherry speciﬁc cell clones (C2
and C4) were sorted with FACS. The separated cells were expanded
for three days in the absence of DOX and re-stimulated with DOX for
48 h. 97–99% of the positive cells retained their inducibility, while
most of the negative cells remained non-responsive in the presence of
DOX (Fig. 4A). This ﬁnding conﬁrms that these ES cells can stably main-
tain their transgene inducibility, even after several rounds of cell divi-
sion. In addition, this result indicates that cell sorting is a very efﬁcient
AB
Fig. 3. Similar transgene induction with high concentration DOX treatment, but enhanced reporter gene expression after G418 re-selection. (A) The mCherry speciﬁc C2 and C4 ES cell
clones were treated with the indicated concentrations of DOX for 2 days. (B) Flow cytometric proﬁles of the mCherry bearing clones (C1–5). ES cells were cultured for 8 days in the
presence or absence of 300 μg/ml G418 and re-stimulated with DOX (1 μg/ml) for 2 days.
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transgenes.
Next we determined the relative gene copy number of mCherry
from the sorted ES cells. The mCherry copy number was measured
with QPCR andnormalized to an intronless endogenous gene (Maf). Ap-
proximately 0.4mCherry/Maf ratios were detected from the sorted pos-
itive cells (Fig. 4B). This value is near to the 0.5 ratio which is expected if
we consider that two copies of Maf gene can be found per cell, but only
one copy of mCherry integrated into the single chromosome X, in these
male ES cells. In striking contrast to the positive cells, however,mCherry
gene was barely detected from the sorted negative cells (Fig. 4B), but
the Cre speciﬁc PCR product was readily detected from these cells (Fig.
4C). Of note, in our genetically modiﬁed ES cells (ZX1) the Cre gene is
supposed to excise itself upon recombination and should be replaced
with the mCherry transgene (Fig. 1). These data suggest that a few
G418 sensitive and reporter free ZX1 like ES cells remained in the ES
cell clones. Consistent with this ﬁnding, the sorted negative cells exhib-
ited a robust cell death upon G418 re-selection and the recovered cells
showed a much stronger reporter gene induction (Fig. 4D). Moreover,
these G418 re-selected ES cells had a higher mCherry/Maf ratio
conﬁrming that the G418 sensitivity and the reporter gene deﬁciency
were tightly associated (Fig. 4E). Together, these results indicated that
a subset of cells within each clone was reporter gene free and this pop-
ulation substantially attributed to the impaired inducibility of the
transgene.3.4. Epigenetic gene silencing can also contribute to the compromised trans-
gene induction
Data shown above demonstrated that we could eliminate large part
of the non-inducible cells with chemical re-selections, however, we
failed to obtain 100% mCherry expression even after a prolonged G418
treatment (Fig. 3B). Moreover, 10–50% of the sorted, non-responsive,
but G418 re-selected ES cells remained refractory to DOX treatment
(Fig. 4D). These results imply that additional mechanisms may contrib-
ute to the impaired transgene induction.We assumed that DNAmethyl-
ation and/or histone acetylation might participate in the repression of
the reporter transgene. To test this possibility, G418 re-selected ES
cells were treated with azadC (5-aza-2′-deoxycytidine) or Na-butyrate
for 48 h. AzadC (Decitabine) is a well-known DNA hypomethylating
agent (Lubbert, 2000). Na-butyrate is an inhibitor of histone
deacetylases (Mariani et al., 2003). In line with the DNA methylation
and histone deacetylation depending silencing, elevated percentage of
mCherry positive cells was detected in the presence of azadC or Na-bu-
tyrate in the G418 re-selected cells (Fig. 5A and B). These ﬁndings sug-
gest that DNAmethylation andhistone acetylation dependent processes
are partly responsible for the transgene repression. However b2%
mCherry positive cells were detected in the sorted samples, which
were not re-selected with G418, in the presence of these inhibitors
(Fig. 5C). Overall, theseﬁndings conﬁrm that the impaired transgene in-




Fig. 4. Genetic heterogeneity of the inducible ES cell clones. (A) Cell sorting of the mCherry carrying ES cell clones (C2 and C4). The mCherry positive ‘P’ and negative cells ‘N’ were
separated by FACS. Post-sorted cells were further cultured for three days without DOX treatment, thereafter re-stimulated with DOX (1 μg/ml) for additional 2 days. (B) Transgene
content of the post-sorted ES cells. Genomic DNA was obtained from the post-sorted reporter positive ‘P’ and negative cells ‘N’. Relative copy number of mCherry was determined by
QPCR and normalized to the Maf gene. (C) Detection of the Cre gene with PCR from the sorted cells. Genomic DNA was obtained from the reporter positive ‘P’ and negative cells ‘N’.
ZX1 ES cell derived DNA was used as a positive control. (D) Flow cytometric proﬁles of the post-sorted negative cells ‘N’ with or without G418 re-selection. The sorted negative ‘N’ ES
cells (C2 and C4) were expanded for 7 days in the presence or absence of 300 μg/ml G418 and re-stimulated with DOX (1 μg/ml) for additional 2 days. (E) Transgene content of the
post-sorted and G418 reselected ES cells. Genomic DNA was obtained from the post-sorted reporter negative cells with or without G418 re-selection. Relative copy number of
mCherry was determined as described in part B.
232 R. Bencsik et al. / Stem Cell Research 17 (2016) 228–234recombined cells, however, epigenetic silencing can also attribute to the
depressed transgene expression, at least in the G418 re-selected ES cell
subsets.
4. Discussion
In this report we have assessed the mCherry induction capacity of a
panel of DOX-regulated, ES cell clones at single cell level. This transgene
was readily upregulated upon DOX exposure, however, the distribution
of the reporter signal was variable among the tested clones. Detecting
variegated gene expression, in an apparently homogeneous cell popula-
tion, is not a novelﬁnding. Itwas described that higher dose of glucocor-
ticoid led to an increased frequency of cells displaying a high level of
reporter expression rather than a uniform increase in expression in
each cell (Ko et al., 1990). In addition, heterogeneous gene induction
was detected in a DOX-inducible cell culture system (Wong et al.,
2005) and variegated EGFP expression was observed in murine ES
cells (Ramunas et al., 2007).
Importantly, our inducible ES cell clones ﬁrmly maintained their
characteristic transgene expression pattern, and the induction capacity
of these DOX-responsive cells was propagated to their progenies sug-
gesting that the observed heterogeneous expression is not the conse-
quence of the random ﬂuctuation of gene expression. We found that
10–50% of the ES cells, within the individual clones, failed to expressany mCherry speciﬁc ﬂuorescence signals. Our analysis revealed that
predominantly a genetic alteration was responsible for the impaired
transgene induction because the mCherry transgene was missing from
the non-responsive cells. There are several possibilities to explain the
origin of this mCherry gene free cell population. Our ES cell clones
might be contaminatedwith non-transgenic cells during the cell line es-
tablishment or expansion. Our PCR analysis failed to support the ES cell
contamination theory because a Cre gene speciﬁc PCR product was de-
tected from the non-responsive (negative) cells suggesting that the
engineered ES cell clones contained non-recombined ZX1 like cells.
These results raise the question how these non-recombined cells sur-
vived the antibiotic selection. Of note, we employed a prolonged (7–
8 days) G418 treatment during the establishment of the ES cell clones.
It is intriguing to speculate that some of the recombined ZX1 cells
might only transiently expressed the neomycin resistant gene due to
the reversible nature of recombination, and these transiently resistant
cells survived the initial selection. Consistent with this possibility, it
was described that the neomycin resistance gene can establish resis-
tance to G418 with minimal expression level in mouse ES cells
(Nakatake et al., 2013). It is also possible that those ZX1 cells which
were located close to a growing resistant ES colony survived the selec-
tion because the nearby resistant cells locally decreased the antibiotic
concentration. Regardless of the exact mechanism, our data suggested




Fig. 5. Elevated transgene expression upon administration of epigenetic modulators. The mCherry speciﬁc, sorted negative ‘N’ ES cell clones (C2 and C4) were expanded for 7 days in the
presence or absence of 300 μg/ml G418. Thereafter they were cultured in the absence or presence 50 μM5-aza-2′-deoxycytidine (azadC) or 20 nMNa-butyrate (Na-B) for 2 days and co-
treated with DOX (1 μg/ml). (A) Representative ﬂow cytometric proﬁles of the negative ‘N’, but G418 re-selected mCherry speciﬁc ES cell clones. (B) Average percentage of the mCherry
expressing cells of the G418 re-selected negative clones (N+G418). (C) Average percentage of themCherry expressing cells of the G418 non-selected negative clones (N−G418). In part
B–C the average and the SD valueswere calculated from 3 independent experiments, in addition, the signiﬁcant differences between the control and treated (azadC or Na-B)mean values
were evaluated using two-tailed, unpaired Student's t-test (NS: non-signiﬁcant, *p b 0.05, **p b 0.01, ***p b 0.001).
233R. Bencsik et al. / Stem Cell Research 17 (2016) 228–234the non-recombined cells during the establishment of the ES cell clones.
To prevent the regeneration of non-resistant cells, permanent chemical
selection is frequently applied, using lower concentration of G418 in
mammalian transgenic cell lines. However permanent G418 selection
cannot be employed automatically in ES cell culture because these plu-
ripotent cells are often maintained on antibiotic sensitive feeder layers.
For example, we routinely cultured and expanded our ES cells on G418
sensitive mouse embryonic ﬁbroblast (MEF) feeder cells because we
had a limited access to the expensive neomycin resistant MEF. Instead
of continuous G418 selection, we recommend a single post-expansion
G418 re-selection which can be employed just before ES cell differenti-
ation, using feeder cell free conditions. The other possible way to isolate
pure transgenic cell lines is dilution cloning or single cell sorting
coupled cloning. However, dilution cloning is rarely used in ES cells; es-
pecially it is difﬁcult to apply it in human ES cells, because these cells can
poorly survive in single cell stage (Merkert and Martin, 2016).
The G418 selectable genetic heterogeneity, only partially explains
the impaired transgene induction capacity of our cells because some
of the G418 re-selected cells remained refractory to DOX treatment.
We assumed that epigenetic silencing also participated in the repres-
sion of the reporter transgene. Consistent with this notion, we found
that G418 re-selected ES cells exhibited an increased transgene expres-
sion upon DNA demethylation or a histone deacetylase inhibitor (Na-
butyrate) treatment suggesting that epigenetic silencing can develop
in this genomic region at least in a subset of the cells. Of note, the bacte-
rial backbone of the p2lox targeting vector is integrated into the X chro-
mosome upon recombination using the ICEmethod (Fig. 1). In addition,
it was described that bacterial DNA fragment can initiate epigenetic si-
lencing (Riu et al., 2007). Therefore it is possible that the inserted bacte-
rial DNA fragment can initiate gene silencing despite the fact that thegenomic region of Hprt has been considered to be a site at which
transgenes express stably (Bronson et al., 1996; Iacovino et al., 2011).
In summary, in this studywe observed that a subset of the transgen-
ic ES cells failed to express the reporter genes upon DOX treatment. Im-
portantly, we can eliminate most of these non-responsive cells with
G418 re-selection. In addition, it is advocated to sort the DOX-respon-
sive cells using reporter transgenes to further enhance the inducibility
of the ES cell clones. Together these improvements allow us to obtain
a uniform DOX-inducible cell population at least ex vivo. We suggest
that these post-cloning selection strategies can enhance the robustness
and the transgenemediated cell conversion capacity of the drug-induc-
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